Research Triangle Park, North Carolina, June 12, 2013 — Marken announced today the successful launch of a new workshop series addressing Quality Agreements between pharmaceutical companies and their supply chain providers. Quality Agreements are increasingly being scrutinized by regulatory authorities during routine audits with a new focus on the supply chain.
As clinical trials continue to grow in challenging and emerging markets, and more medicines that require temperature control enter the supply chain, well developed Quality Agreements have become crucial.
Last week, representatives from major Pharma companies came together with industry experts to discuss the increasing importance and impact of these new requirements for the clinical trial industry. This first workshop focused on the quality of existing templates, and recently published updates to regulations and associated guidelines.
Additional Marken Quality Agreement workshops will take place this September in Chicago and San Francisco, as well as Vienna this October. More information is available on the Marken website.